Bayer's (BAYRY) AskBio Advances Parkinson Disease Study
Subjects will receive either bilateral image-guided infusion of AAV2-GDNF into the putamen, single dose (active treatment arm) or bilateral partial burr/twist holes (control arm). The trial ...
Zacks via Yahoo
6 days ago